You are here

Mutations

Two new studies indicate Paxlovid's usefulness in helping prevent hospitalization, death in COVID outpatients

Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Omicron XBB.1.5 variant expands US dominance except to northwest

...the CDC said the more transmissible XBB.15 subvariant makes up an estimated 74.7% of cases, up from 66.4% last week. The only area where the subvariant isn't dominant is in the far northwestern region, which includes Alaska, Idaho, Oregon, and Washington.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Mutations
howdy folks
Page loaded in 0.670 seconds.